Renalytix

0 followers

‌

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links

Org chart

James McCullough

CEO

James McCullough

Collapse

Co-Founder

Co-Founder

CTO

Chief Medical Officer

Jed Fulk

Vice President Of Sales

Anna Flynn

Director, Quality System Compliance And Eh&s

Elise Wilfinger

Chief Strategy & Marketing Officer

Anita M.

Lab Technical Supervisor

Azadeh Zabetian

Senior Medical Science Liaison

Christopher Woytovich

Clinical Laboratory Scientist (cls)

Katherine Edwards PhD

Senior R&d Scientist

Noor Alyassin, MD

Research Assistant

Kate Brennan, CFA

Senior Manager, Strategic Finance

Christopher Scott

Chief Operating Officer

Justin DiVenuta

Regional Sales Director

Tony McNicholas

Staff Data Engineering And Data Science

Joe Fraas, MBA

Regional Sales Director

Teams

+11

Management Team

14 members

Healthcare and Clinical Science

7 members

Leadership Team

3 members

Sales Team

3 members

Product Management and Development Team

4 members

Similar companies

Summit Therapeutics

4 followers

4D Molecular Therapeutics

3 followers

Pivot Bio

2 followers

Matica Biotechnology

1 follower

Thermo Fisher Scientific

166 followers

Kura Oncology

17 followers

Exact Sciences

15 followers

CRISPR Therapeutics

10 followers

United Therapeutics

7 followers

Transnetyx

1 follower

Kippa

53 followers

Explore companies